These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19106338)

  • 1. World's drug supply chain needs better oversight, FDA says.
    Traynor K
    Am J Health Syst Pharm; 2009 Jan; 66(1):12-3. PubMed ID: 19106338
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA embraces RFID to protect drug supply.
    Young D
    Am J Health Syst Pharm; 2004 Dec; 61(24):2612, 2615. PubMed ID: 15646694
    [No Abstract]   [Full Text] [Related]  

  • 3. RFID implementation not moving fast enough, FDA says.
    Young D
    Am J Health Syst Pharm; 2006 Mar; 63(6):500-2. PubMed ID: 16522876
    [No Abstract]   [Full Text] [Related]  

  • 4. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK
    Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA recognition of first-world drug regulators as means of relieving U.S. drug shortages.
    Hunnisett-Dritz D
    Am J Health Syst Pharm; 2012 Oct; 69(19):1626, 1628. PubMed ID: 22997113
    [No Abstract]   [Full Text] [Related]  

  • 6. Canadian drugs: panacea or problem?
    State Legis; 2004 Jun; 30(6):9. PubMed ID: 15179953
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: Bioavailability, bioequivalence and bias.
    Leopold IH
    Am J Ophthalmol; 1975 Mar; 79(3):518. PubMed ID: 1122003
    [No Abstract]   [Full Text] [Related]  

  • 8. Multinational medicines--ensuring drug quality in an era of global manufacturing.
    Okie S
    N Engl J Med; 2009 Aug; 361(8):737-40. PubMed ID: 19692686
    [No Abstract]   [Full Text] [Related]  

  • 9. US drug shortages are set to reach record high in 2011, report says.
    Tanne JH
    BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical counterfeiting and the RFID technology intervention.
    Coustasse A; Arvidson C; Rutsohn P
    J Hosp Mark Public Relations; 2010 Jul; 20(2):100-15. PubMed ID: 20582850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counterfeits kill!
    Ghebrehiwet T
    Imprint; 2006; 53(3):40-4. PubMed ID: 16821529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Securing the US pharmaceutical supply.
    Somberg JC
    Am J Ther; 2008; 15(3):197. PubMed ID: 18496255
    [No Abstract]   [Full Text] [Related]  

  • 13. Warn patients of imported drug dangers.
    Edmunds M
    Nurse Pract; 2003 Mar; 28(3):70. PubMed ID: 12800698
    [No Abstract]   [Full Text] [Related]  

  • 14. ASHP, other groups, advise FDA about solving counterfeit drug problems.
    Young D
    Am J Health Syst Pharm; 2003 Dec; 60(23):2406, 2408, 2411. PubMed ID: 14686215
    [No Abstract]   [Full Text] [Related]  

  • 15. Report suggests steps to improve safety of drug supply.
    Traynor K
    Am J Health Syst Pharm; 2011 Sep; 68(17):1570, 1574. PubMed ID: 21856799
    [No Abstract]   [Full Text] [Related]  

  • 16. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
    Simmons HE
    Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901
    [No Abstract]   [Full Text] [Related]  

  • 17. As production goes global, drug supply faces greater risks to safety, quality.
    Kuehn BM
    JAMA; 2011 Aug; 306(8):811-3. PubMed ID: 21862736
    [No Abstract]   [Full Text] [Related]  

  • 18. Consumer alert on foreign drugs.
    FDA Consum; 2003; 37(2):4. PubMed ID: 12715750
    [No Abstract]   [Full Text] [Related]  

  • 19. Risks and benefits of importing prescription medications from lower-income countries.
    Dhalla IA; Detsky AS
    JAMA; 2008 Sep; 300(12):1453-5. PubMed ID: 18812537
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: FDA oversight.
    ; Berry MD; White RS
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-96. PubMed ID: 25775703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.